Cargando…
Targeting the disordered C-terminus of PTP1B with an allosteric inhibitor
PTP1B, a validated therapeutic target for diabetes and obesity, plays a critical positive role in HER2 signaling in breast tumorigenesis. Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chemical properties of the active site. We defined a novel mechanism of allosteric...
Autores principales: | Krishnan, Navasona, Koveal, Dorothy, Miller, Daniel H., Xue, Bin, Akshinthala, Sai Dipikaa, Kragelj, Jaka, Jensen, Malene Ringkjøbing, Gauss, Carla-Maria, Page, Rebecca, Blackledge, Martin, Muthuswamy, Senthil K., Peti, Wolfgang, Tonks, Nicholas K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062594/ https://www.ncbi.nlm.nih.gov/pubmed/24845231 http://dx.doi.org/10.1038/nchembio.1528 |
Ejemplares similares
-
Establishing conditions for the generation and maintenance of estrogen receptor-positive organoid models of breast cancer
por: Oliphant, Michael UJ, et al.
Publicado: (2023) -
Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development
por: Krishnan, Navasona, et al.
Publicado: (2018) -
Enthalpy–Entropy Compensation in the Promiscuous Interaction of an Intrinsically Disordered Protein with Homologous Protein Partners
por: Kragelj, Jaka, et al.
Publicado: (2021) -
Visualizing protein breathing motions associated with aromatic ring flipping
por: Mariño Pérez, Laura, et al.
Publicado: (2022) -
Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids
por: Huang, Ling, et al.
Publicado: (2021)